Dual-Pricing Controversy: Sequoia and VCs Face Scrutiny Over Startup Valuations

The usually opaque world of venture capital has been rocked by recent public accusations, shedding light on controversial valuation practices that could be distorting the perception of startup success. At the heart of the storm is a practice dubbed 'dual-pricing,' where a startup's announced valuation might be drastically different from what lead investors actually pay for the bulk of their stake, leading to concerns about transparency and fairness for employees and smaller investors.

Quick summary

• Brendan Foody, co-founder of the AI talent platform Mercor, publicly accused elite VC firm Sequoia of routinely employing a 'dual-pricing' strategy in recent funding rounds.
• This controversial tactic involves lead venture capital firms investing the majority of their capital at a lower, preferential valuation, while a smaller, often symbolic, portion is used to establish a much higher 'headline' valuation for public announcement.
• The practice raises significant concerns about its impact on employee stock options and angel investors, who may be operating under inflated perceptions of a company's worth, though independent 409A valuations for employees are intended to provide a more grounded figure.
• Shaun Maguire of Sequoia defended the firm's approach, characterizing it as a rare, market-driven necessity to participate in highly competitive 'hot' deals, particularly within the AI sector, rather than a deliberate attempt to mislead.

Why it matters

The integrity of startup valuations underpins trust across the entire technology ecosystem. When headline figures diverge significantly from actual investment terms, it creates a cascade of implications for various stakeholders. For founders, the allure of a high valuation can attract talent and further investment, but at what cost to their credibility and the true financial literacy of their team? For employees, who often trade immediate salary for future equity, a misleading valuation can distort their understanding of their compensation's real value, affecting financial planning and trust in leadership. Angel investors, typically less sophisticated than institutional VCs, are particularly vulnerable, lacking the protective layers of independent appraisals. Moreover, a pervasive culture of inflating metrics, whether through dual-pricing or manipulated revenue figures, can create an unrealistic market environment, potentially leading to misallocation of capital and unsustainable growth expectations across the industry. Ultimately, this erodes the transparency vital for a healthy, functioning private market.

Background

The current discussion around venture capital ethics is not entirely new, but it has gained new momentum. For some time, founders and early-stage investors have increasingly used platforms like X (formerly Twitter) to voice frustrations over perceived mistreatment and opaque practices by venture capitalists. These complaints have ranged from unprofessional conduct during pitches to more substantive issues concerning investment terms. The underlying pressure stems from a hyper-competitive venture landscape, especially in high-growth sectors like artificial intelligence, where VCs are fiercely competing for stakes in promising companies. This intense competition often pushes firms to find creative ways to secure deals, sometimes at the expense of clear, straightforward valuation communication. While specific instances of VCs investing at different valuations within the same round have been reported previously by industry publications, the direct accusation against a firm as prominent as Sequoia by a successful founder marks a more public and pointed escalation of these long-simmering tensions.

The Mechanics of 'Dual-Pricing'

The core of the controversy lies in a nuanced but impactful funding mechanism. In a 'dual-tranche' or 'dual-pricing' round, a lead venture capital firm commits a substantial portion of its investment at a valuation significantly lower than what is publicly announced. Simultaneously, a smaller, often nominal, part of the round is structured at a much higher 'headline' valuation. This higher figure is then widely publicized, creating the perception of a market darling and a significant win for the startup. However, the lead investor's average entry price remains considerably lower than what the public, or even some stakeholders, might infer from press releases.

The disparity between these figures can be striking. For instance, when AI-driven IT helpdesk startup Serval announced a $75 million Series B funding round at a $1 billion valuation, the full picture was reportedly more complex. According to The Wall Street Journal, Sequoia’s actual lowest entry point valued the company at just $400 million, less than half the figure broadcast. Similarly, for Aaru, a startup utilizing AI for market research, lead investor Redpoint reportedly backed the company at a $450 million valuation, despite an announced headline price of $1 billion. These gaps represent a significant divergence between market perception and the underlying financial realities for key investors.

Sequoia's Stance and Market Realities

In response to Brendan Foody's direct accusation, Shaun Maguire, a partner at Sequoia, pushed back on the characterization of the practice as a 'scam.' Maguire acknowledged seeing this behavior, but stated it had occurred approximately five times during his seven years at Sequoia. He framed the situation not as a deliberate deceptive maneuver but as a consequence of market dynamics. According to Maguire, other investors are often willing to pay higher prices for particularly 'hot' companies, especially those in the AI space, exceeding what Sequoia might deem appropriate. To still maintain a relationship with the company and secure a stake, Sequoia sometimes decouples its company-building relationship from the capital, resulting in two tranches with different valuations in close succession.

Maguire emphasized that 'VC is a repeated game,' implying that misleading people would be counterproductive to long-term trust and relationships. He also invited Foody to share any specific instances of 'shady' behavior he had witnessed. However, his explanation notably did not delve into what founders communicate to those who are not privy to the details of the lower-valuation tranches, leaving open questions about the level of transparency afforded to all stakeholders.

Impact on Employees and Angel Investors

The implications of dual-pricing resonate differently across a startup's ecosystem. For employees, the situation is complex. Jason Woo, a partner in valuation and financial modeling at Armanino, notes that the stock options granted to employees should theoretically be valued based on the blended price across all tranches, not just the higher headline figure. This valuation is typically determined by an independent 409A appraisal, which aims to set the fair market value of a private company’s shares and dictates the strike price employees pay for their options, independent of public announcements.

However, there's a significant caveat. 409A valuations are widely understood to often skew lower. This is because a lower strike price for employee options translates to a smaller tax bill for the company, creating a structural incentive to keep the valuation modest. Consequently, while the 409A is designed to protect employees from an inflated headline valuation, it also might not fully reflect the top end of a company's perceived market worth. Employees, therefore, may not be paying the headline price but could still be getting a partial picture of the valuation landscape.

The situation for angel investors is even more precarious. Unlike employees, who receive options priced via an independent appraisal, angel investors write checks directly. There is no independent third-party appraiser mediating between an angel and the valuation figure presented by a founder. This lack of an intermediary leaves angel investors more susceptible to potentially inflated or misrepresented valuations if founders choose not to disclose the intricacies of a multi-tranche round.

Beyond Valuations: The ARR Conundrum

The dual-pricing structure is not an isolated phenomenon in the venture capital world. It represents just one of several tactics employed by VCs and founders to manage or 'game' the perception of success within a intensely competitive market. Another prevalent strategy involves the manipulation or outright overstatement of Annual Recurring Revenue (ARR), a key metric for SaaS and subscription-based businesses that is closely watched by investors.

Niko Bonatsos, a veteran VC and founder of Verdict Capital, highlighted this issue at a recent TechCrunch event. He recounted instances where founders would present significantly inflated ARR figures, only to clarify upon inquiry that these numbers were based on highly optimistic projections, sometimes extrapolating from a single successful marketing campaign over a short period (e.g., '365 times the revenue we made yesterday because one of our campaigns hit'). Such practices indicate that even fundamental business metrics can be massaged to create a more favorable impression, further obscuring a company’s genuine financial health and growth trajectory.

Qnews24h insight

The 'dual-pricing' debate is more than a public spat; it's a symptom of deeper systemic tensions within the private capital markets, particularly exacerbated by the frothy valuations seen in 'hot' sectors like AI. This strategy reflects a difficult balancing act for venture capitalists: the imperative to secure stakes in competitive deals, the desire to maintain a reputation for backing market leaders (often driven by headline valuations), and the underlying need for attractive financial returns. While Sequoia's defense points to market realities, the core issue remains one of information asymmetry. When different valuations are applied to the same funding round without clear, consistent disclosure to all stakeholders, it inevitably fosters distrust. This trend, coupled with other forms of metric manipulation, underscores an urgent need for greater transparency and potentially more robust, standardized reporting in private markets. Without it, the perception of success risks becoming dangerously disconnected from reality, undermining confidence and potentially leading to less efficient capital allocation in the long run.

Sources

• Mercor’s Brendan Foody calls out Sequoia over 'dual-pricing' valuation tricks | TechCrunch

FAQ

What is 'dual-pricing' in venture capital funding?

'Dual-pricing' or 'two-tranche' refers to a funding mechanism where a lead venture capital firm invests a significant portion of its capital at a lower, preferential valuation, while a smaller, often symbolic, portion of the round is publicly announced at a much higher 'headline' valuation. This creates a disparity between the perceived and actual investment value.

Why do VCs use dual-pricing strategies?

Venture capital firms, especially in competitive markets like the AI sector, may use dual-pricing to secure stakes in highly sought-after companies while managing their own financial exposure. By investing most capital at a lower valuation, they ensure a better average entry price, while the higher headline valuation helps create market buzz, attract talent, and maintain a perception of backing successful ventures, without overpaying for the bulk of their investment.

How does dual-pricing affect startup employees and angel investors?

For employees, stock options should ideally be valued based on a blended price derived from all tranches, assessed by an independent 409A valuation. However, 409A valuations often skew low due to tax incentives for companies, meaning employees may not get the full, highest picture of the company's worth. Angel investors are more vulnerable as they directly write checks without the protection of an independent appraiser, making them susceptible to potentially inflated valuations if not fully informed about the multi-tranche structure.

Is 'dual-pricing' an illegal practice?

The source material does not state that 'dual-pricing' is illegal. While it raises concerns about transparency and potential for misleading stakeholders, particularly employees and angel investors, and may be viewed by some as 'shady,' it's presented as a complex market practice. The debate often centers on ethical disclosure and the spirit of fair dealing rather than explicit illegality, especially given the lack of independent oversight for private market valuations compared to public markets.